This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Pukac, L. A. Articles by Karnovsky, M. J. Search for Related Content PubMed PubMed Citation Articles by Pukac, L. A. Articles by Karnovsky, M. J.

American Journal of Pathology, Vol 139, 1501-1509, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Antiproliferative effects of novel, nonanticoagulant heparin derivatives on vascular smooth muscle cells in vitro and in vivo

LA Pukac, GM Hirsch, JC Lormeau, M Petitou, J Choay and MJ Karnovsky
Department of Pathology, Harvard Medical School, Boston, Massachusetts 02115.

The proliferation of vascular smooth muscle cells (VSMC) is strongly inhibited by whole heparin both in vitro and in vivo. To identify and characterize antiproliferative, but nonanticoagulant heparin derivatives, heparin fragments made by periodate treatment were produced and acylated with 2-, 4-, or 6-carbon chain lengths. In culture, the 4- and 6-carbon acylated compounds were more effective than whole heparin in inhibiting serum stimulated VSMC growth at equal mass or approximately equal mean molar concentrations. Further testing was performed in the rat carotid balloon injury model. Myointimal VSMC proliferation produced by balloon catheterization of rat carotid arteries was inhibited by the 4-carbon acylated compound as effectively as heparin at the same mass dose. Importantly, unlike heparin, the 4- carbon acylated compound had no anticoagulant effect in vivo. These experiments suggest nonanticoagulant, acylated heparin derivatives may have a pharmacologic role in preventing myointimal proliferative lesions that are responsible for failures of vascular surgeries and angioplasties.

This article has been cited by other articles:

				K. Krueger, P. Landwehr, M. Bendel, M. Nolte, H. Stuetzer, R. Bongartz, M. Zaehringer, G. Winnekendonk, A. Gossmann, R.-P. Mueller, et al. Endovascular Gamma Irradiation of Femoropopliteal de Novo Stenoses Immediately after PTA: Interim Results of Prospective Randomized Controlled Trial Radiology, August 1, 2002; 224(2): 519 - 528. [Abstract] [Full Text] [PDF]

				W.-H. Fan and M. J. Karnovsky Increased MMP-2 Expression in Connective Tissue Growth Factor Over-expression Vascular Smooth Muscle Cells J. Biol. Chem., March 15, 2002; 277(12): 9800 - 9805. [Abstract] [Full Text] [PDF]

				H. G. Garg, B. T. Thompson, and C. A. Hales Structural determinants of antiproliferative activity of heparin on pulmonary artery smooth muscle cells Am J Physiol Lung Cell Mol Physiol, November 1, 2000; 279(5): L779 - L789. [Abstract] [Full Text] [PDF]

				C. Campo, J. F. Molinari, J. Ungo, and T. Ahmed Molecular-weight-dependent effects of nonanticoagulant heparins on allergic airway responses J Appl Physiol, February 1, 1999; 86(2): 549 - 557. [Abstract] [Full Text] [PDF]

				R. L. Geary, N. Koyama, T. W. Wang, S. Vergel, and A. W. Clowes Failure of Heparin to Inhibit Intimal Hyperplasia in Injured Baboon Arteries : The Role of Heparin-Sensitive and -Insensitive Pathways in the Stimulation of Smooth Muscle Cell Migration and Proliferation Circulation, June 15, 1995; 91(12): 2972 - 2981. [Abstract] [Full Text]